These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 23903334)

  • 1. DSM-5 criteria for substance use disorders: recommendations and rationale.
    Hasin DS; O'Brien CP; Auriacombe M; Borges G; Bucholz K; Budney A; Compton WM; Crowley T; Ling W; Petry NM; Schuckit M; Grant BF
    Am J Psychiatry; 2013 Aug; 170(8):834-51. PubMed ID: 23903334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).
    Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E
    Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue?
    Budney AJ
    Addiction; 2006 Sep; 101 Suppl 1():125-33. PubMed ID: 16930169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study.
    Cottler LB; Leung KS; Abdallah AB
    Addiction; 2009 Oct; 104(10):1679-90. PubMed ID: 19681802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimensionality of hallucinogen and inhalant/solvent abuse and dependence criteria: implications for the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition.
    Kerridge BT; Saha TD; Smith S; Chou PS; Pickering RP; Huang B; Ruan JW; Pulay AJ
    Addict Behav; 2011 Sep; 36(9):912-8. PubMed ID: 21621334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed changes in DSM-III substance use disorders: description and rationale.
    Rounsaville BJ; Spitzer RL; Williams JB
    Am J Psychiatry; 1986 Apr; 143(4):463-8. PubMed ID: 3953889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to DSM-5 criteria linked papers in drug and alcohol dependence.
    Hasin DS
    Drug Alcohol Depend; 2012 Apr; 122(1-2):20-1. PubMed ID: 22137644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescents and substance-related disorders: research agenda to guide decisions on Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V).
    Crowley TJ
    Addiction; 2006 Sep; 101 Suppl 1():115-24. PubMed ID: 16930168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DSM-5: important changes in the field of addictive diseases].
    Heinz A; Friedel E
    Nervenarzt; 2014 May; 85(5):571-7. PubMed ID: 24737037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revising Substance-Related Disorders in the DSM-5: A History.
    Zachar P; First MB; Kendler KS
    J Stud Alcohol Drugs; 2022 Jan; 83(1):99-105. PubMed ID: 35040765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater Prevalence of Proposed ICD-11 Alcohol and Cannabis Dependence Compared to ICD-10, DSM-IV, and DSM-5 in Treated Adolescents.
    Chung T; Cornelius J; Clark D; Martin C
    Alcohol Clin Exp Res; 2017 Sep; 41(9):1584-1592. PubMed ID: 28667763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5.
    Baker TB; Breslau N; Covey L; Shiffman S
    Addiction; 2012 Feb; 107(2):263-75. PubMed ID: 21919989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How should we revise diagnostic criteria for substance use disorders in the DSM-V?
    Martin CS; Chung T; Langenbucher JW
    J Abnorm Psychol; 2008 Aug; 117(3):561-75. PubMed ID: 18729609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement between DSM-III and III-R substance use disorders.
    Cottler LB; Helzer JE; Mager D; Spitznagel EL; Compton WM
    Drug Alcohol Depend; 1991 Dec; 29(1):17-25. PubMed ID: 1797516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measures of substance consumption among substance users, DSM-IV abusers, and those with DSM-IV dependence disorders in a nationally representative sample.
    Moss HB; Chen CM; Yi HY
    J Stud Alcohol Drugs; 2012 Sep; 73(5):820-8. PubMed ID: 22846246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordance between DSM-III-R and DSM-IV diagnoses of substance use disorders in adolescents.
    Mikulich SK; Hall SK; Whitmore EA; Crowley TJ
    Drug Alcohol Depend; 2001 Feb; 61(3):237-48. PubMed ID: 11164688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICD-10?
    Hughes JR; Oliveto AH; Helzer JE; Higgins ST; Bickel WK
    Am J Psychiatry; 1992 Jan; 149(1):33-40. PubMed ID: 1728182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Addictive behaviours from DSM-IV to DSM-5].
    van den Brink W
    Tijdschr Psychiatr; 2014; 56(3):206-10. PubMed ID: 24643833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CIDI-core substance abuse and dependence questions: cross-cultural and nosological issues. The WHO/ADAMHA Field Trial.
    Cottler LB; Robins LN; Grant BF; Blaine J; Towle LH; Wittchen HU; Sartorius N
    Br J Psychiatry; 1991 Nov; 159():653-8. PubMed ID: 1756341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine dependence, abuse and craving: dimensionality in an Israeli sample.
    Shmulewitz D; Keyes KM; Wall MM; Aharonovich E; Aivadyan C; Greenstein E; Spivak B; Weizman A; Frisch A; Grant BF; Hasin D
    Addiction; 2011 Sep; 106(9):1675-86. PubMed ID: 21545668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.